Fellows of ASCO (FASCO) Recipients For Last Quarter

The American Society of Clinical Oncology (ASCO) has announced the latest recipients of the Fellow of the American Society of Clinical Oncology (FASCO) award.

Originally launched in 2007 as the ASCO Statesman Award, the FASCO honors members for their extraordinary volunteer service, engagement, and dedication to ASCO and the Association for Clinical Oncology. This distinction recognizes ASCO’s most active members and encourages greater involvement in ASCO initiatives.

FASCO status is awarded to eligible members who meet the required FASCO points through their contributions to ASCO’s mission.

Robin Zon, President of ASCO for 2024-2025, congratulated the 2024 FASCO recipients on LinkedIn, saying:

“Your efforts, commitment, and dedication to ASCO’s mission and members and ultimately our patients, are greatly appreciated. Without you, ASCO as an organization would not be able to achieve what we’ve been able to do thus far. Thank you so very much to all of our volunteers and congratulations to these amazing FASCO recipients!”

Here are the 2025 FASCO honorees:

Nishin Bhadkamkar, MD, FASCO

Dr. Nishin Bhadkamkar is a professor in the Department of General Oncology at The University of Texas MD Anderson Cancer Center, with a joint appointment in the Department of Gastrointestinal (GI) Medical Oncology. He is also recognized as an MD Anderson Distinguished Educator and a member of the MDACC Academy of Health Science Education, contributing to oncology education and clinical practice.

Mehmet Copur, MD, FACP, FASCO

Dr. Mehmet Sitki Copur is a nationally recognized medical oncologist and an adjunct faculty professor at the University of Nebraska Medical Center in the Department of Internal Medicine, Division of Hematology/Oncology.

He earned his medical degree from Hacettepe University in Ankara, Turkey, and completed his Internal Medicine Residency there before continuing his training in the United States. He completed an internship and residency at Chicago Medical School and pursued a medical oncology fellowship at the National Cancer Institute in Bethesda, Maryland.

Robert M. Daly, MD, MBA, FASCO

Dr. Robert Daly is a medical oncologist specializing in lung cancer at Memorial Sloan Kettering Cancer Center. He is also a health services researcher focused on improving cancer care systems. His research addresses care disparities, overuse of aggressive treatments, and quality of care delivery. As an ASCO health policy fellow, he works on policy interventions to improve the value of cancer care. Dr. Daly served as an Advocacy Champion for ASCO (2022-2023).

Aakash Desai, MD, MPH, FASCO

Dr. Aakash Desai is an Assistant Professor of Medicine at the O’Neal Cancer Center, University of Alabama Birmingham. His research focuses on evidence-based oncology, clinical trials, drug development, healthcare delivery, and quality of cancer care, with a particular interest in Thoracic Oncology.

He has been recognized with multiple honors, including the Conquer Cancer Foundation ASCO Young Investigator Award (2021) and ASCO Merit Awards (2021, 2022).

Sharad Goyal, MD, MS, FASTRO, FASCO

Dr. Sharad Goyal is the Director of the Division of Radiation Oncology and a Professor of Radiology at The George Washington University Medical Faculty Associates.

His research focuses on improving radiation treatment for cancer patients and integrating data from cardiology and oncology to inform treatment and survivorship. Dr. Goyal has advanced techniques like IMRT, SRS, SBRT, and PBT in cancer management. He is also a 2024 ASTRO Fellow (FASTRO).

Petros Grivas, MD, PhD, FASCO

Dr. Petros Grivas is a board-certified medical oncologist specializing in genitourinary (GU) cancers, including bladder, prostate, and testicular cancer. He is a Professor in the Division of Hematology and Oncology at the University of Washington School of Medicine and serves as the Clinical Director of the GU Cancers Program.

Dr. Grivas’ clinical research has contributed to the FDA approval of new drugs for bladder cancer, and he currently leads trials investigating checkpoint inhibitors—immunotherapy drugs that enhance the immune system’s ability to fight cancer.

Shilpi Gupta, MD, FASCO

Dr. Shilpi Gupta is a hematologist and oncologist specializing in breast cancer, head and neck cancers, and benign hematology disorders. She is the Associate Program Director of the Hematology and Oncology Fellowship Program at Atlantic Health System and serves as a mentor to residents and fellows.

Dr. Shilpi Gupta is actively involved with the American Society of Clinical Oncology (ASCO) and has contributed to numerous research publications, earning multiple awards.

Alan S. Coates, MD, FRACP, FASCO

Dr. Alan Coates is an Australian professor of clinical oncology, medical researcher, and administrator. He was the inaugural CEO of Cancer Council Australia (1998–2006) and has held leadership roles, including president of the Clinical Oncological Society of Australia (COSA) and co-chair of the St. Gallen International Breast Cancer Conference.

Dr. Coates was also the first non-American elected to the board of directors of the American Society of Clinical Oncology (ASCO). He is a Fellow of the Royal Australasian College of Physicians (FRACP).

Jack Hensold, MD, FASCO

Dr. Jack Hensold is the medical director for regional outreach at Bozeman Health Deaconess Regional Medical Center and a member of ASCO’s Clinical Practice Committee. He also serves as chair of the ASCO Rural Health Access in Montana Task Force. Through his work with ASCO, Dr. Hensold gained a broader understanding of cancer care delivery and became focused on addressing challenges in rural areas. He ultimately established a hub-and-spoke model of cancer care in his community to improve access and treatment for patients.

Steve Lee, MD, FACP, FASCO

Dr. Steve Lee is a medical oncologist specializing in gastrointestinal and genitourinary cancers. His work focuses on improving cancer care delivery through health system innovations and public policy. He practices at Kaiser Permanente in Northern California, where he contributes to efforts in quality care and value. Originally from Yuba City, CA, Dr. Lee trained on the East Coast before returning to California in 2019.

Sagar Lonial, MD, FACP, FASCO

Dr. Sagar Lonial is a medical oncologist specializing in multiple myeloma at the Winship Cancer Institute. He leads the bone marrow transplantation and clinical trials teams and is board-certified in hematology and medical oncology.

Dr. Lonial holds leadership roles in several professional organizations, including ASCO and ASH, and serves as the Chief Medical Officer at Winship. He is a professor at Emory University School of Medicine.

Alison W. Loren, MD, MSCE, VIS, FACP, FASCO

Dr. Alison Loren is the Chief of the Division of Hematology-Oncology at the Perelman School of Medicine and Director of Blood and Marrow Transplantation at the Abramson Cancer Center. She is a professor of medicine and specializes in hematologic malignancies.

Dr. Loren is the senior author of ASCO’s Fertility Preservation Guidelines and has been actively involved with the Center for International Blood and Marrow Transplant Research (CIBMTR). She also holds an elected position on the Executive Committee of the American Society of Hematology (ASH).

Paul L. Nguyen, MD, MBA, FASCO

Dr. Paul Nguyen is a leading expert in prostate cancer clinical care and research. He has published over 350 research articles and holds national leadership roles, including Co-Chair of the NCI GU Steering Committee and Chair of the ASTRO Annual Refresher Course.

He is the Principal Investigator of major clinical trials such as FORMULA-509, NRG GU-009/PREDICT-RT, and ENZARAD, with research funded by an NIH R01 grant. Dr. Nguyen serves as Genitourinary Clinical Center Director for Radiation Oncology at Dana-Farber/Brigham and Women’s Cancer Center, Vice-Chair for Clinical Research in Radiation Oncology, and Professor at Harvard Medical School.

Sandip Patel, MD, FASCO

Dr. Sandip Patel is a medical oncologist specializing in cancer immunotherapy and early-phase clinical trials. As part of UC San Diego Health’s Precision Immunotherapy Clinic, he works to develop personalized therapies that help the immune system fight cancer more effectively.

In addition to his clinical work, Dr. Patel is a professor in the Department of Medicine, where his research focuses on identifying biomarkers for tailored immunotherapy and optimizing treatment combinations to improve patient outcomes.

Mina S. Sedrak, MD, MS, FASCO

Dr. Mina Sedrak is an Associate Professor of Medicine and Director of the Cancer and Aging Program at UCLA. His research explores how cancer therapies accelerate aging, and he leads clinical trials to develop interventions that mitigate these effects. He earned his M.D. from Rush Medical College and an M.S. in Health Policy from the University of Pennsylvania.

Davendra Sohal, MD, MPH, FASCO

Dr. Sohal is a board-certified medical oncologist specializing in gastrointestinal cancers. As a Professor of Medicine at the University of Cincinnati, he leads clinical trials on innovative cancer therapies. He serves as the Director of Experimental Therapeutics and Associate Director for Clinical Research at the UC Cancer Center, focusing on expanding clinical trial options and improving patient access to care.

Tom Stinchcombe, MD, FASCO

Dr. Tom Stinchcombe, MD, FASCO, is a Professor of Medicine and a leading expert in thoracic oncology at Duke Cancer Institute. He specializes in treating lung cancers, including non-small cell lung cancer, small cell lung cancer, and mesothelioma. Dr. Stinchcombe focuses on clinical care, clinical trials, and developing new therapies.

Erica M. Stringer-Reasor, MD, FASCO

Dr. Erica M. Stringer-Reasor is an Associate Professor of Medicine at the University of Alabama at Birmingham, specializing in aggressive women’s cancers, including triple-negative and HER2+ breast cancer and high-grade serous ovarian cancer.

She focuses on early-phase clinical trials, drug development, and translational research. As a clinician-scientist, she bridges laboratory discoveries with clinical applications, designing trials to advance cancer treatment.

Alexandra Thomas, MD, FACP, FASCO

Dr. Alexandra Thomas, MD, FACP, FASCO, is a medical oncologist and Professor of Medicine at Duke Cancer Institute. Dr. Thomas is also passionate about advancing cancer treatments, and reducing side effects of cancer treatments while offering new hope through innovative therapies. Outside of her work, she loves traveling, knitting, and spending quality time with her family, especially exploring the beauty of North Carolina.

Robert A. Wolff, MD, FASCO

Dr. Robert A. Wolff, MD, FASCO, is a Professor of Medicine in the Department of GI Medical Oncology at MD Anderson Cancer Center, where he also serves as the Deputy Division Head for Clinical and Educational Affairs in the Division of Cancer Medicine. Additionally, he is the ad interim Program Director for the Hematology/Oncology Fellowship. Dr. Wolff has been recognized with the Excellence in Education and Mentorship Award for his outstanding contributions to education and mentorship at MD Anderson.

See also 2025 FASCO Recipients Part 1 and Part 2.